FDA to Watson on 24-week Trelstar: Ummm, not yet. Oh, and to Bayer and J&J for Xarelto: Ummmm, not yet. Bayer's Yaz and blood clots - the legal wrangling continues. Solvay selling out on pharma, …
Today’s Top (8) in Pharma 050709
This will probably be the last Top Three post for about a week or so, as I head out to Chicago for the SPBT (Society of Pharmaceutical and Biotech Trainers) conference. And there's a bit of backlog …
Today’s Top Three in Pharma 040209
Solvay shopping its drug business. Belgian conglomerate Solvay is eying an exit of the drug business with a sale of its pharmaceutical division that could be worth upwards of €5 billion, or $6.6 …